HMNC BRAIN HEALTH | a disruptive clinical stage biopharma company pioneering precision psychiatry

Um den vollen visuellen und funktionalen Umfang dieser Website genießen zu können, aktivieren sie bitte Javascript in ihrem Browser.

Team

Executive Team HMNC Team Scientific Advisory Board

HMNC BRAIN HEALTH SUPERVISORY BOARD

Leaders from the academic, business, and pharmaceutical field

Dr. Franz B.
Humer

Chairman HMNC Holding GmbH
Former Chairman and CEO Roche Holding Ltd

Carsten
Maschmeyer

CEO Maschmeyer Group
Early- & Growth-stage Investor

Prof. Thomas
Szucs MD

Director of the European Center of Pharmaceutical Medicine

Adalbert Freiherr
von Uckermann

Managing Director of Jahr Group,
Hamburg, since 01 July 2020

Innovation

HMNC Brain Health develops game-changing therapies for mental health disorders

Vision &
Mission

Develop personalized precision psychiatry treatments with AI, setting new standards in psychiatric care.

Excellence

HMNC Brain Health uses state-of-the-art scientific methods to develop future oriented therapies for mental health disorders - based on deep insight into the genomics in mental health

Team

HMNC BRAIN HEALTH SUPERVISORY BOARD

Dr. Franz B.Humer

CarstenMaschmeyer

Prof. ThomasSzucs MD

Adalbert Freiherrvon Uckermann